Biotech & Healthcare

Revelstoke Capital Partners is a Denver-based private equity firm focused on building industry-leading companies in the healthcare and related business services sectors. The firm partners with entrepreneurs and management teams to execute a disciplined organic and acquisition growth strategy, aiming to build exceptional companies. Since its inception in 2013, Revelstoke has raised over $2.3 billion in equity and completed 65 acquisitions, including 17 platform companies and 48 add-on acquisitions.

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Pittsburgh Life Sciences Greenhouse (PLSG) is a leading life sciences investment firm in Western Pennsylvania, dedicated to fostering innovation and commercialization in the life sciences sector. PLSG supports entrepreneurs and emerging companies by providing funding, strategic guidance, and access to resources, with a focus on improving healthcare outcomes and driving economic growth in the region. The firm is deeply connected to the growing impact of data analytics in healthcare and is committed to supporting underserved groups through initiatives like the 'Under 40, Underserved Advisory Board'.

Bering Capital is a venture capital firm with a passion for investing in extraordinary people and cutting-edge biotech and medical technology companies. The firm is dedicated to transforming groundbreaking ideas into world-class companies by leveraging its expertise in identifying critical problems and acting decisively. Bering Capital draws on lessons from early Silicon Valley pioneers and its own entrepreneurial ventures to shape the early DNA of companies for success. The firm believes in the primacy of great markets and great people, all aligned with one mission.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

3E Bioventures Capital is a venture capital firm focused on life sciences, investing in global health innovators. The firm targets Biotech, including new drugs, modalities, and drug discovery platforms, as well as TechBio, which merges biology and technology to disrupt traditional paradigms. 3E Bioventures follows a science-driven, entrepreneur-friendly investment approach, collaborating with companies and research institutions to develop solutions for unmet medical needs. The firm's philosophy is encapsulated in its name, 3E: Expertise, Efficiency, Execution.

Solasta Ventures, Inc., a wholly-owned subsidiary of Aju IB Investment, is a leading venture capital firm based in South Korea. The firm is dedicated to investing in innovative companies that aim to advance the standard of care for diseases with unmet medical needs. Solasta Ventures leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms with the potential to transform patients' lives worldwide.

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

Brain Trust Accelerator Fund is a venture capital firm focused on impact investing in brain-related diseases. The firm specializes in translational stage investments that address the diagnosis and treatment of these diseases. With a strong track record, Fund I has generated top-tier returns, benefiting up to ten million patients and delivering significant charitable contributions. The firm leverages scientific advancements and market opportunities to invest in early-stage, translational research, aiming to transform pioneering research into meaningful clinical benefits.

Pappas Capital is a global venture capital and commercial development firm dedicated to advancing life science discoveries and bringing groundbreaking solutions to market. With over 30 years of experience, the firm has invested in more than 90 companies across the United States, Canada, and Asia, focusing on life sciences, agriculture, and technology. Pappas Capital operates through three main lines of business: Pappas Ventures, Specialized Fund Management, and Translational Medicine, partnering with research universities to accelerate scientific discoveries.

HealthCap is a European venture capital firm specializing in life sciences, with a focus on investing in breakthrough therapies for diseases with high unmet medical needs. Since its founding in 1996, HealthCap has raised eight funds and has been instrumental in backing and building over 130 companies, leading to more than 45 public offerings and numerous trade sales. The firm is dedicated to fostering innovation in healthcare, aiming to make a significant impact on patient outcomes and societal health.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Research Corporation Technologies (RCT) is a technology investment and management company based in Tucson, Arizona. Founded in 1987, RCT provides early-stage funding and development for promising biomedical companies and technologies, focusing on innovations originating from universities and research institutions worldwide. With assets exceeding $500 million, RCT advances technology development through venture investments, partnerships, and special licensing programs, supporting the commercialization of academic innovations.

Venture Investors is a leading venture capital firm based in the Midwest, focusing on healthcare innovations. With access to renowned research universities and vibrant communities, the firm targets and invests in groundbreaking ideas that shape the future of health and wellness. They manage $275 million in assets and have a proven track record of success in driving healthcare advancements.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.